These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17620628)

  • 21. Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic.
    Menard D; Djalle D; Yapou F; Manirakiza A; Talarmin A
    Am J Trop Med Hyg; 2006 Feb; 74(2):205-10. PubMed ID: 16474071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
    Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh.
    van den Broek IV; van der Wardt S; Talukder L; Chakma S; Brockman A; Nair S; Anderson TC
    Trop Med Int Health; 2004 Jun; 9(6):680-7. PubMed ID: 15189458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
    Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
    Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
    Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
    Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
    Hamour S; Melaku Y; Keus K; Wambugu J; Atkin S; Montgomery J; Ford N; Hook C; Checchi F
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):548-54. PubMed ID: 15869770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.
    Lucchi NW; Okoth SA; Komino F; Onyona P; Goldman IF; Ljolje D; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3995-4002. PubMed ID: 25896703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
    Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
    Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use.
    Noranate N; Durand R; Tall A; Marrama L; Spiegel A; Sokhna C; Pradines B; Cojean S; Guillotte M; Bischoff E; Ekala MT; Bouchier C; Fandeur T; Ariey F; Patarapotikul J; Le Bras J; Trape JF; Rogier C; Mercereau-Puijalon O
    PLoS One; 2007 Jan; 2(1):e139. PubMed ID: 17206274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changing landscape of Plasmodium falciparum drug resistance in the Democratic Republic of Congo.
    Deutsch-Feldman M; Aydemir O; Carrel M; Brazeau NF; Bhatt S; Bailey JA; Kashamuka M; Tshefu AK; Taylor SM; Juliano JJ; Meshnick SR; Verity R
    BMC Infect Dis; 2019 Oct; 19(1):872. PubMed ID: 31640574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.
    Mbonye AK; Birungi J; Yanow SK; Shokoples S; Malamba S; Alifrangis M; Magnussen P
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5475-82. PubMed ID: 26124154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018.
    Guerra AP; Olivera MJ; Cortés LJ; Chenet SM; Macedo de Oliveira A; Lucchi NW
    Malar J; 2022 Oct; 21(1):306. PubMed ID: 36307852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.
    Baraka V; Ishengoma DS; Fransis F; Minja DT; Madebe RA; Ngatunga D; Van Geertruyden JP
    Malar J; 2015 Nov; 14():439. PubMed ID: 26542942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ; Basco LK; Mazabraud A
    Sante; 2002; 12(4):363-7. PubMed ID: 12626289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.
    Kublin JG; Cortese JF; Njunju EM; Mukadam RA; Wirima JJ; Kazembe PN; Djimdé AA; Kouriba B; Taylor TE; Plowe CV
    J Infect Dis; 2003 Jun; 187(12):1870-5. PubMed ID: 12792863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Return of chloroquine antimalarial efficacy in Malawi.
    Laufer MK; Thesing PC; Eddington ND; Masonga R; Dzinjalamala FK; Takala SL; Taylor TE; Plowe CV
    N Engl J Med; 2006 Nov; 355(19):1959-66. PubMed ID: 17093247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
    Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
    J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology.
    Alifrangis M; Enosse S; Pearce R; Drakeley C; Roper C; Khalil IF; Nkya WM; Rønn AM; Theander TG; Bygbjerg IC
    Am J Trop Med Hyg; 2005 Feb; 72(2):155-62. PubMed ID: 15741552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.